Skip to main content
. 2024 Jul 3;7(7):e2420259. doi: 10.1001/jamanetworkopen.2024.20259

Table 2. Associations Between Environmental Toxicants (62 Exposures) and Depressive Symptoms in 3427 Adults (ExWAS Analysis).

Exposure family by toxicant exposure Processing Median (IQR) Model 1a Model 2b
OR (95% CI) P valuec OR (95% CI) P valuec
Acrylamide and glycidamide
Acrylamide log(ln) 42.9 (32.8-64.2) 1.18 (1.09-1.28) <.001 1.14 (1.05-1.24) .007
Glycidamide log(ln) 38.4 (28.1-54.5) 1.15 (1.06-1.25) .002 1.10 (1.01-1.20) .07
Speciated arsenics
Arsenobetaine 2 Categories NA 0.97 (0.83-1.14) .79 1.02 (0.86-1.20) .87
Arsenocholine 2 Categories NA 0.87 (0.70-1.07) .22 0.90 (0.72-1.12) .43
Arsenous acid 2 Categories NA 0.83 (0.71-0.98) .04 0.90 (0.76-1.07) .34
Dimethylarsinic acid log(ln) 3.5 (2.2-5.7) 0.95 (0.86-1.05) .38 0.95 (0.86-1.06) .48
Monomethylarsonic acid 2 Categories NA 0.88 (0.75-1.04) .17 0.95 (0.81-1.13) .65
Ethylene oxide
Ethylene oxide log(ln) 21.1 (15.1-42.2) 1.23 (1.15-1.31) <.001 1.17 (1.09-1.25) <.001
Formaldehyde
Formaldehyde log(ln) 132.0 (121.0-144.0) 1.01 (0.94-1.09) .79 1.02 (0.94-1.11) .65
Iodine
Iodine log(ln) 124.3 (76.9-222.9) 0.98 (0.89-1.09) .79 0.94 (0.84-1.05) .37
Metals
Copper log(ln) 115.1 (99.0-133.6) 1.24 (1.12-1.37) <.001 1.04 (0.93-1.17) .55
Selenium log(ln) 128.8 (118.9-139.8) 0.90 (0.82-0.99) .05 0.95 (0.86-1.05) .45
Zinc log(ln) 80.4 (70.9-90.4) 0.88 (0.79-0.97) .02 0.93 (0.83-1.04) .3
Barium log(ln) 1.1 (0.6-2.0) 0.93 (0.84-1.02) .16 0.94 (0.85-1.04) .34
Cadmium log(ln) 0.2 (0.1-0.4) 1.23 (1.10-1.37) <.001 1.13 (0.99-1.28) .12
Cobalt log(ln) 0.4 (0.3-0.6) 1.10 (1.00-1.21) .08 1.02 (0.91-1.13) .83
Cesium log(ln) 4.2 (3.1-5.9) 0.91 (0.82-1.01) .09 0.91 (0.81-1.01) .14
Mercury 2 categories NA 0.93 (0.79-1.09) .46 1.01 (0.85-1.20) .92
Manganese 2 categories NA 1.32 (1.11-1.56) .002 1.21 (1.02-1.45) .07
Molybdenum log(ln) 37.2 (24.8-54.4) 0.94 (0.85-1.03) .23 0.93 (0.84-1.03) .22
Lead log(ln) 0.3 (0.2-0.5) 1.12 (1.01-1.24) .06 1.05 (0.94-1.18) .48
Antimony log(ln) 0 (0-0.1) 1.17 (1.07-1.28) .002 1.09 (0.99-1.21) .13
Tin log(ln) 0.4 (0.2-0.9) 1.29 (1.17-1.42) <.001 1.16 (1.04-1.30) .02
Strontium log(ln) 96.2 (59.4-148.8) 0.99 (0.90-1.08) .79 0.99 (0.90-1.09) .92
Thallium log(ln) 0.2 (0.1-0.2) 0.87 (0.79-0.96) .008 0.89 (0.80-0.99) .07
Tungsten log(ln) 0.1 (0-0.1) 1.11 (1.00-1.22) .06 1.08 (0.97-1.20) .22
Uranium log(ln) 0 (0-0) 1.22 (1.11-1.34) <.001 1.17 (1.06-1.30) .01
Nicotine metabolites
TNE-2 log(ln) 0 (0-1.3) 1.51 (1.37-1.67) <.001 1.42 (1.26-1.59) <.001
Total cotinine log(ln) 0.5 (0.2-86.1) 1.44 (1.31-1.58) <.001 1.33 (1.20-1.49) <.001
Total hydroxycotinine log(ln) 0.9 (0.3-157.2) 1.51 (1.37-1.67) <.001 1.41 (1.26-1.59) <.001
PAH
1-Napthol log(ln) 1392.5 (708.1-4718.5) 1.39 (1.26-1.54) <.001 1.28 (1.15-1.42) <.001
2-Napthol log(ln) 5664.4 (2898.7-10 933.4) 1.42 (1.26-1.59) <.001 1.21 (1.07-1.37) .008
3-Hydroxyfluorene log(ln) 71.7 (42.5-189.7) 1.30 (1.19-1.43) <.001 1.21 (1.09-1.34) .001
2-Hydroxyfluorene log(ln) 174.8 (109.8-382.4) 1.39 (1.27-1.53) <.001 1.27 (1.14-1.40) <.001
1-Hydroxyphenanthrene log(ln) 104.6 (69.1-169.7) 1.22 (1.10-1.35) <.001 1.13 (1.01-1.26) .06
1-Hydroxypyrene log(ln) 131.6 (80.5-225.0) 1.27 (1.14-1.41) <.001 1.15 (1.03-1.29) .04
2- and 3-Hydroxyphenanthrene log(ln) 127.5 (82.8-209.0) 1.26 (1.14-1.40) <.001 1.16 (1.03-1.29) .03
Perchlorate, nitrate, and thiocyanate
Nitrate log(ln) 42 911.3 (30 973.3-63 739.6) 1.01 (0.92-1.10) .92 1.04 (0.95-1.14) .52
Thiocyanate log(ln) 1049.0 (532.2-2212.7) 1.18 (1.07-1.29) .002 1.10 (1.00-1.22) .10
Perchlorate log(ln) 2.6 (1.6-4.3) 0.96 (0.87-1.07) .54 0.96 (0.86-1.07) .54
VOC metabolites
2,2DCVMA 2 categories NA 1.04 (0.89-1.22) .66 1.35 (0.80-2.27) .34
2MHA log(ln) 31.8 (14.8-73.1) 1.16 (1.04-1.29) .01 1.14 (1.02-1.28) .05
3 and 4 MHA log(ln) 189.7 (94.1-508.0) 1.29 (1.14-1.45) <.001 1.25 (1.09-1.42) .005
AAMA log(ln) 50.9 (31.8-90.0) 1.20 (1.09-1.32) <.001 1.14 (1.02-1.26) .04
AMCC log(ln) 145.1 (78.3-262.9) 1.29 (1.16-1.43) <.001 1.17 (1.04-1.31) .02
ATCA log(ln) 121.9 (60.8-227.2) 1.09 (0.98-1.21) .13 0.96 (0.85-1.08) .55
BMA log(ln) 6.5 (4.0-11.4) 0.98 (0.89-1.07) .67 0.92 (0.84-1.02) .19
BPMA log(ln) 3.9 (1.7-9.8) 0.89 (0.79-0.99) .05 0.92 (0.82-1.03) .24
CEMA log(ln) 97.2 (61.9-161.1) 1.40 (1.27-1.54) <.001 1.29 (1.17-1.43) <.001
CYMA log(ln) 1.7 (1.0-8.7) 1.28 (1.20-1.37) <.001 1.22 (1.14-1.31) <.001
DHBMA log(ln) 303.3 (232.3-400.9) 1.20 (1.10-1.30) <.001 1.12 (1.02-1.23) .04
GAMA 2 Categories NA 1.37 (1.17-1.60) <.001 1.31 (1.11-1.55) .005
HEMA 2 Categories NA 1.35 (1.16-1.58) <.001 1.27 (1.08-1.50) .01
2HPMA log(ln) 27.8 (17.7-51.3) 1.21 (1.10-1.32) <.001 1.19 (1.08-1.30) .002
3HPMA log(ln) 238.0 (146.2-460.5) 1.28 (1.17-1.40) <.001 1.22 (1.11-1.35) <.001
MA log(ln) 133.0 (93.0-196.2) 1.25 (1.14-1.36) <.001 1.16 (1.06-1.28) .007
MHBMA2 2 Categories NA 2.02 (1.63-2.50) <.001 1.74 (1.38-2.18) <.001
MHBMA3 log(ln) 4.7 (2.9-9.6) 1.31 (1.20-1.43) <.001 1.22 (1.11-1.34) <.001
PHEMA 2 Categories NA 1.35 (1.16-1.58) <.001 1.21 (1.03-1.43) .05
PGA log(ln) 201.7 (144.6-289.9) 1.15 (1.06-1.26) .002 1.08 (0.99-1.18) .16
PMA 2 Categories NA 1.00 (0.85-1.17) .97 0.98 (0.83-1.16) .83
HPMMA log(ln) 214.3 (148.7-427.0) 1.31 (1.21-1.43) <.001 1.22 (1.11-1.33) <.001

Abbreviations: 2,2DCVMA, N-acetyl-S-(2,2-dichlorovinyl)-l-cysteine; AAMA, 2-carbamoylethylmercapturic acid; AMCC, methylcarbamoylmercapturate; ATCA, 2-aminothiazoline-4-carboxylic acid; BMA, benzylmercapturic acid; BPMA, N-acetyl-S-(n-propyl)-l-cysteine; CEMA, N-acetyl-S-(2-carboxyethyl)-l-cysteine; CYMA, N-acetyl-S-(2-cyanoethyl)-l-cysteine; DHBMA, dihydroxy-butyl-mercapturic acid; ExWAS, exposome-wide association study; GAMA, carbamoyl-2-hydroxyethylmercapturate; HEMA, 2-hydroxyethylmercapturic acid; HPMA, hydroxypropylmercapturic acid; HPMMA, 3-hydroxy-1-methyl-propylmercapturic acid; MA, mandelic acid; MHA, methylhippuric acid; MHBMA, N-acetyl-S-(2-hydroxy-3-butenyl)-l-cysteine; NA, not applicable; OR, odds ratio; PAH, polycyclic aromatic hydrocarbon; PGA, polyglutamic acid; PHEMA, poly(2-hydroxyethyl methacrylate); PMA, phenylmercapturic acid; TNE-2, total nicotine equivalent-2; VOC, volatile organic compound.

a

Unadjusted model.

b

Constructed by adjusting for sex, age, race and Hispanic ethnicity, educational level, the ratio of family income to poverty, body mass index, sleep duration, alcohol consumption, estimated glomerular filtration rate, sample collection time, 6-month survey period, and survey cycles.

c

Adjusted to control the false discovery rate at 5%.